Senti Biosciences's total assets for Q2 2024 were $86.91M, a decrease of -14.95% from the previous quarter. SNTI total liabilities were $42.77M for the fiscal quarter, a -7.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.